Left Ventricular Assist Device Market Size And Share

  • Report Code : TIPRE00018950
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 159
Buy Now

Left Ventricular Assist Device Market Size, Share, and Growth 2022-2028

Buy Now

Left Ventricular Assist Device Market Report Left Ventricular Assist Device Market Scope and Analysis Left Ventricular Assist Device Market Size and Share

Left Ventricular Assist Device Market: Strategic Insights

Left Ventricular Assist Device Market

  • CAGR (2021 - 2028)
    5.1%
  • Market Size 2021
    US$ 1.27 Billion
  • Market Size 2028
    US$ 1.81 Billion

Market Dynamics

GROWTH DRIVERS
  • Rising prevalence of cardiovascular diseases
  • Increase in minimally invasive procedures
FUTURE TRENDS
  • Development of more compact and efficient devices
  • Use of AI for real-time monitoring
OPPORTUNITIES
  • Growth in heart failure treatment options
  • Expansion in outpatient and ambulatory care

Key Players

  • ABIOMED Inc
  • Abbott Laboratories
  • Medtronic Plc
  • LivaNova Plc
  • Jarvik Heart Inc
  • Terumo Corp
  • Berlin Heart GmbH
  • BiVACOR Inc
  • Evaheart Inc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Type of Flow
  • Pulsatile and Non-Pulsatile
Design
  • Implantable Ventricular Assist Devices and Transcutaneous Ventricular Assist Devices
Application
  • Bridge-to-Transplantation
  • Destination Therapy
  • Bridge-to-Recovery
  • Bridge-to-Candidacy